Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference
About Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform,
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
(Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome’s management will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare Conference on Tuesday,
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
About Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. An NDA for its lead candidate, DCCR (diazoxide choline) extended-release tablets,
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that management will participate in the Piper Sandler 36 th Annual Healthcare Conference on Wednesday,
Yahoo Finance19h
Apyx Medical Corporation (APYX)
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary ...
Hosted on MSN3mon
APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024
Apyx Medical (NASDAQ:APYX) just reported results for the second quarter of 2024. Apyx Medical reported earnings per share of -19 cents. This was above the analyst estimate for EPS of -20 cents.
The Middletown Press20d
Apyx: Q3 Earnings Snapshot
CLEARWATER, Fla. (AP) — CLEARWATER, Fla. (AP) — Apyx Medical Corporation (APYX) on Friday reported a loss of $4.7 million in its third quarter. On a per-share basis, the Clearwater ...
Nasdaq19d
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and ...